Stem Cell Global Blueprint Conference 2010 - Agenda

AGENDA
Day 1 – Friday May 21

7:00	Registration & Breakfast – MaRS Centre (Auditorium A, B & C) 7:00 am – 8:00 am
7:45	Welcome & Keynote Addresses 7:45 – 8:50 am • Dr. Michael Fehlings (Krembil Neuroscience Centre Chair Toronto Western Hospital / Acute Care & Treatment – Practice Network Lead, Rick Hansen Institute – Canada) • Mr. Bill Barrable (CEO, Rick Hansen Institute – Canada) • Mr. James Price (CEO Stem Cell Foundation)
8:50	Scientific Researcher Perspective: “Current State of Stem Cells Laboratory Discoveries” 8:50 am – 9:30 am Moderator • Dr. Charles Tator (Professor of Neurosurgery, Former Campeau Family Chair, Toronto Western Hospital – Canada) Speakers • Dr. Andras Nagy (Senior Investigator, Samuel Lunenfeld Research Institute, Mount Sinai – University of Toronto – Canada) • Dr. Derek van der Kooy (Professor, Dept. of Medical Genetics & Microbiogy, McEwen Centre for Regeneration – University of Toronto – Canada) • Dr. Geoff Raisman (Professor and Chair of Neural Regeneration – UCL Institute of Neurology – UK) Panel Discussion / Audience Questions 9:30 am – 9:50 am Panel Discussion / Audience Questions Audience Table Breakout Session 9:50 am – 10:20 am
10:20	Morning Break
10:30	Government / Regulator Perspective: “Regulation of Stem Cells” 10:30 am – 11:50 am Moderator • Dr. James Guest (Associate Professor, Neurological Surgery, The Miami Project To Cure Paralysis – USA) Speakers • Dr. Alok Sharma (NeuroGen Brain – India) • Dr. Reinaldo Guimaràes – (Ministry of Health – Brazil) • Dr. Wilson W. Bryan (Division of Clinical Evaluation and Pharmacology/Toxicology, Office of Cellular, Tissue and Gene Therapies Centre for Biologics Evaluation and Research – FDA, USA) • Dr. Patrick Celis – (CAT Secretariat, European Medicines Agency – UK) • Prof. James Lawford-Davies (Lecturer in Law and Medicine at Newcastle University – UK) • Dr. Qiu Renzong (Ministry of Health – China) • Dr. Peter Ganz (Director of the Centre for Blood and Tissue Evaluation, Biologics and Genetics Therapies Directorate (BGTD) – Health Canada – Canada) Panel Discussion / Audience Questions 11:50 am – 12:10 pm Audience Table Breakout Session 12:10 am – 12:40 pm
12:40	Lunch Keynote Address • Dr. Thomas Okarma (President, CEO and Director, Geron Corp. – USA)
1:35	Clinical Researcher Perspective: “Stem Cell Clinical Trials” 1:25 pm – 2:35 pm Moderator • Dr. Eve Tsai (Neurosurgeon, The Ottawa Hospital; Assistant Professor, Division of Neurosurgery, University of Ottawa – Canada) Speakers • Dr. Alan Mackay-Sim (Researcher – Griffith University, Eskitis Institute for Cell and Molecular Therapies – Australia) • Dr. Hatem Sabaawy (Clinical Researcher – Cairo University – Egypt, and the Cancer Institute of New Jersey, UMDNJ/RWJMS) • Dr. Antonio Carlos Campos de Carvalho (Director of the National Cardiology Institute – Brazil) • Dr. Rosalia Mendez-Otero (Universidade Federal do Rio de Janeiro – Brazil) • Dr. Huang Hongyun (President, International Association of Neural Restoration, Beijing) • Dr. Samuel Abraham (Director Nichi-In Centre for Regenerative Medicine – India) Panel Discussion / Audience Questions 2:35 pm – 2:55 pm Audience Table Breakout Session 2:55 pm – 3:25 pm
3:25	Afternoon Break
3:35	Bioethics & Policy Perspective: “Ethics & Policies Surrounding Stem Cell Research, and Therapeutic Application” 3:35 pm – 4:35 pm Moderator • Ms. Rosario Isasi, JD, MPH (Research Associate – Centre of Genomics & Policy, Mc Gill University & Genome Quebec Innovation Centre – Canada) Speakers • Ms. Dominique McMahon (Doctoral Graduate Student – McLaughlin-Rotman Centre for Global Health – Canada) • Mr. Bernard Siegel (Executive Director of the Genetics Policy Institute – USA) • Dr. Zhai Xiaomei (Medical Professor – Center for Bioethics- Peking Union Medical College – China) • Ms. Helen Gavaghan (Science Tech and Policy Writer – UK) • Prof. Timothy Caulfield, LLM, FRSC (Canada Research Chair in Health Law & Policy, University of Alberta – Canada) Panel Discussion / Audience Questions 4:35 pm – 4:55 pm Audience Table Breakout Session 4:55 pm – 5:25 pm
5:25	Day 1 Concluding Remarks 5:25 pm – 5:30 pm • Dr. Charles Tator (Professor of Neurosurgery, Former Campeau Family Chair, Toronto Western Hospital – Canada) Evening Break 5:30 pm – 7:00 pm
7:00	Reception & Dinner at Azure (InterContinental Hotel) 7:00 pm – 10:00 pm

Day 2 – Saturday May 22

7:00	Registration & Breakfast – MaRS Centre (Auditorium A, B & C) 7:00 am – 8:00 am
8:00	Morning Address & Results of Day 1 Breakout Sessions 8:00 – 8:20 am • Dr. Michael Fehlings (Krembil Neuroscience Centre Chair Toronto Western Hospital / Acute Care & Treatment – Practice Network Lead within the Rick Hansen Institute – Canada)
8:20	Industry Perspective: “Stem Cell Commercialization” 8:20 am – 9:20 am Moderator • Dr. Mark Rohrbaugh (Director, Office of Technology Transfer – National Institutes of Health) Speakers • Dr. Karl Johe (Chief Scientific Officer of NeuralStem Inc. USA) • Dr. Stephen Huhn (VP of StemCells Inc. – USA) • Mr. Douglas Sipp (RIKEN Center for Developmental Biology – Japan) • Dr. Javier Diez (Senior Researcher of HistoCell S.L. – Spain) • Deputy Minister George Ross (Ministry of Research & Innovation – Ontario, Canada) Panel Discussion / Audience Questions 9:20 am – 9:40 am Audience Table Breakout Session 9:40 am – 10:10 am
10:10	Morning Break
10:20	Consumers / Family / Patient Advocacy Perspective: Understanding Demand & Risk Acceptance For Stem Cell Therapies” 10:20 – 11:30 am Moderator • Michael Johnson (Director of the Ontario SCI Solutions Alliance – Canada) Speakers • Mr. Bill Adair (Executive Director of Canadian Paraplegic Association) • Dr. Kim Anderson-Erisman (The Miami Project to Cure Paralysis – USA) • Mr. Raven Benny (QuadPara Association of South Africa (QASA) Chairman – South Africa) • Dr. Claes Hultling – (Visiting Professor, Stanford University – USA / Spinalis SCI Unit – Stockholm) • Mrs. Carole Chebero (Neurocore Physiotherapy (B. Kin., B.Ed., MSc(P.T.), Cert. Pilates Instructor – Canada) • Dr. Judy Illes (Professor – National Core for Neuroethics / University of British Colombia – Canada) Panel Discussion / Audience Questions 11:30 am – 11:50 am Audience Table Breakout Session 11:50 am – 12:20 pm
12:20	Lunch
1:05	Funder Perspective: – “What Is The Value Of Stem Cell Research?” 1:05 pm – 2:05 pm Moderator • Dr. Chris McBride (Translational Research Director – Rick Hansen Institute – Canada) Speakers • Dr. Keith Hayes (Chair of the Ontario Neurotrauma Foundation – Canada) • Ms. Susan Howley (Director of Research and Executive Vice President of the Christopher & Dana Reeve Foundation – USA) • Dr. Naomi Kleitman (Program Director of Repair & Plasticity – NIH – USA) • Dr. Stephanie Williams (CEO, Spinal Cord Injury Network – Australia) • Dr. Eric Marcotte (Associate Director, Regenerative Medicine and Nanomedicine (RMNI), Canadian Institutes of Health Research (CIHR) – Canada) Panel Discussion / Audience Questions 2:05 pm – 2:25 pm Audience Table Breakout Session 2:25 pm – 2:55 pm
2:55	Afternoon Break
3:05	Clinical Spinal Cord Injury Researcher Perspective: “Challenges In Translating Basic Science Discoveries Into Spinal Cord Injury Clinical Trials” 3:05 pm – 4:05 pm Moderator • Dr. Michael Fehlings (Krembil Neuroscience Centre Chair Toronto Western Hospital / Acute Care & Treatment – Practice Network Lead within Rick Hansen Institute – Canada) Speakers • Dr. James Guest (Clinical Researcher – The Miami Project – USA) • Dr. Koichi Iwatsuki (Researcher at Osaka University – Japan) • Dr. David Choi (Clinician Researcher at the University College London – UK) • Dr. Armin Curt, Switzerland (Professor and Chairman – Spinal Cord Injury Center, University of Zurich – Switzerland) • Dr. Wolfram Tetzlaff (University of British Columbia – Canada) Panel Discussion / Audience Questions 4:05 pm – 4:25 pm Audience Table Breakout Session 4:25 pm – 4:55 pm
4:55	Day 2 Break Session Results & Concluding Remarks 4:55 pm – 5:30 pm • Dr. Michael Fehlings (Krembil Neuroscience Centre Chair Toronto Western Hospital / Acute Care & Treatment – Practice Network Lead, Rick Hansen Institute – Canada) Adjournment 5:30 pm